Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ViCentra Believes Smaller Is Better For Insulin Pumps

Executive Summary

Medtech Insight spoke to the manufacturers of the smallest commercially available insulin pump to learn more about how it works, the market factors impacting it, and how scaling up a business can throw up unexpected challenges.

You may also be interested in...



”Honey, I Shrunk My Hybrid Closed Loop Insulin Delivery System” – ViCentra’s Kaleido Launches

The closed loop system market is getting busier and busier; however ViCentra is hoping that its Kaleido system, one of the smallest pumps available, will be differentiated enough to secure market share.

Minute Insight: Insulet Launches Long-Awaited Omnipod 5 Tubeless Insulin Pump

Omnipod 5 is the first tubeless automated insulin delivery system compatible with Dexcom’s G6 continuous glucose monitoring system to automatically adjust insulin levels.

Medicare Expands Coverage Of Continuous Glucose Monitors

US Medicare has issued a final rule broadening coverage of continuous glucose monitors, including those integrated with Medtronic insulin pumps. The rule classifies adjunctive monitors, which treat diabetes, as durable medical equipment under the Medicare Part B benefit.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT144960

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel